First Human Trial of SARS-CoV-2 Vaccine: Initial Results In
Researchers from China report the initial findings of the first human trial for a potential vaccine against SARS-CoV-2, the new coronavirus. The results are promising, suggesting that the vaccine is mostly safe and apparently effective.
At present, there are numerous clinical trials around the world testing potential vaccines against the new coronavirus, SARS-CoV-2.
The first human trial for such a vaccine started in early March. It is the work of researchers from several Chinese institutions, including the China National Institute for Food and Drug Control in Beijing, the Beijing Institute of Biotechnology, and the Chinese vaccine company CanSino ...